Goldman Sachs analyst Niraj Shah initiated coverage of ALS Ltd. with a Buy rating and A$14.60 price target. The firm believes ALS is positioned to benefit from short-term mining exploration and long-term green metals trends, while being relatively insulated from labor shortages. Its Commodities business should see continuing high margins short term, while its Life Sciences business grows, Goldman adds.
Published first on TheFly
